Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Suk Ryu

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypesKonstantinos Ntostoglou, Sofia D P Theodorou, Tanja Proctor, et al.
Annals of Surgical Oncology|February 25, 2014
Combined morphologic and molecular classification for predicting lymph node metastasis in early-stage colorectal adenocarcinomaHan Suk Ryu, Woo Ho Kim, Soyeon Ahn, et al.
Scientific Reports|June 16, 2017
Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancerJi Young Kim, Hyebin Lee, Jongmin Woo, et al.
Nature Communications|January 27, 2023
Epigenetic regulation of Neuregulin 1 promotes breast cancer progression associated to hyperglycemiaChanghu Lee, Min Kim, Chanho Park, et al.
Plos One|March 24, 2017
Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanismJiwoo Lee, Bok Sil Hong, Han Suk Ryu, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|December 22, 2017
Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinomaJung-Il Choi, Eung-Ho Cho, Sang Bum Kim, et al.
Scientific Reports|June 20, 2020
Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancerDong-Hyeon Ha, Ahrum Min, Seongyeong Kim, et al.
Thyroid : Official Journal of the American Thyroid Association|April 19, 2014
Expression of indoleamine 2,3-dioxygenase and infiltration of FOXP3+ regulatory T cells are associated with aggressive features of papillary thyroid microcarcinomaHan Suk Ryu, Young Soo Park, Hyo Jin Park, et al.
Proteomics. Clinical Applications|February 25, 2018
Integrated Multi-Omic Analyses Support Distinguishing Secretory Carcinoma of the Breast from Basal-Like Triple-Negative Breast CancerMin-Sun Jin, Hyebin Lee, Jongmin Woo, et al.
Scientific Reports|September 14, 2017
Gene expression profiling of calcifications in breast cancerSung Ui Shin, Jeonghoon Lee, Ju Han Kim, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypesKonstantinos Ntostoglou, Sofia D P Theodorou, Tanja Proctor, et al.
Annals of Surgical Oncology|February 25, 2014
Combined morphologic and molecular classification for predicting lymph node metastasis in early-stage colorectal adenocarcinomaHan Suk Ryu, Woo Ho Kim, Soyeon Ahn, et al.
Scientific Reports|June 16, 2017
Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancerJi Young Kim, Hyebin Lee, Jongmin Woo, et al.
Nature Communications|January 27, 2023
Epigenetic regulation of Neuregulin 1 promotes breast cancer progression associated to hyperglycemiaChanghu Lee, Min Kim, Chanho Park, et al.
Plos One|March 24, 2017
Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanismJiwoo Lee, Bok Sil Hong, Han Suk Ryu, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|December 22, 2017
Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinomaJung-Il Choi, Eung-Ho Cho, Sang Bum Kim, et al.
Scientific Reports|June 20, 2020
Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancerDong-Hyeon Ha, Ahrum Min, Seongyeong Kim, et al.
Thyroid : Official Journal of the American Thyroid Association|April 19, 2014
Expression of indoleamine 2,3-dioxygenase and infiltration of FOXP3+ regulatory T cells are associated with aggressive features of papillary thyroid microcarcinomaHan Suk Ryu, Young Soo Park, Hyo Jin Park, et al.
Proteomics. Clinical Applications|February 25, 2018
Integrated Multi-Omic Analyses Support Distinguishing Secretory Carcinoma of the Breast from Basal-Like Triple-Negative Breast CancerMin-Sun Jin, Hyebin Lee, Jongmin Woo, et al.
Scientific Reports|September 14, 2017
Gene expression profiling of calcifications in breast cancerSung Ui Shin, Jeonghoon Lee, Ju Han Kim, et al.
Pageof 15